WOODCLIFF LAKE, N.J., Nov. 20, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, November 28, 2012, at 10:00 A.M. EST to review its results of operations for the quarter ended September 30, 2012. Par is privately held and does not generally make its financial information available to the public. However, holders of Par's debt securities, certain prospective holders of Par's debt securities and research analysts who cover or intend to cover Par and its debt securities may participate in the conference call and request access to the secured area of its website, in which Par provides access to its financial reports and certain other information relating to its business. Detailed information concerning access to the conference call and to Par's reporting package is posted on Par's secured website at www.parpharm.com/financialinfo.
About Par Pharmaceutical Companies, Inc.
Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.
SOURCE Par Pharmaceutical Companies, Inc.